BRIEF published on 07/08/2025 at 22:15, 1 year ago GENFIT annonce son contrat de liquidité semestriel avec le Crédit Industriel et Commercial Biopharmaceutique Crédit Industriel Maladies Du Foie Liquidité De GENFIT Négociations 2025
PRESS RELEASE published on 07/08/2025 at 22:10, 1 year ago Genfit: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial GENFIT announces half-year report of liquidity contract with Crédit Industriel et Commercial, detailing trading activities and resources as of June 30, 2025 Liquidity Contract Financial Report Crédit Industriel Et Commercial Trading Activities GENFIT
PRESS RELEASE published on 07/08/2025 at 22:10, 1 year ago Genfit : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial GENFIT annonce le bilan semestriel de son contrat de liquidité avec le Crédit Industriel et Commercial, incluant les transactions et moyens de liquidité au 30 juin 2025 Contrat De Liquidité Bilan Semestriel Transactions Crédit Industriel Et Commercial GENFIT
BRIEF published on 06/17/2025 at 20:35, 1 year 1 month ago L'Assemblée Générale de GENFIT approuve les résolutions du Conseil d'Administration Resolutions Produits Biopharmaceutiques Assemblée Générale Des Actionnaires GENFIT Maladies Du Foie
BRIEF published on 06/17/2025 at 20:35, 1 year 1 month ago GENFIT's Shareholder Meeting Approves Board's Resolutions Biopharmaceuticals Resolutions Liver Diseases Shareholders Meeting GENFIT
PRESS RELEASE published on 06/17/2025 at 20:30, 1 year 1 month ago GENFIT: June 17, 2025 Combined Shareholders Meeting Results GENFIT announces approval of all resolutions at June 17, 2025 Combined Shareholders Meeting. Exception: resolution n°28 rejected. Quorum: 27.21% Resolutions Approval Quorum Shareholders Meeting GENFIT
PRESS RELEASE published on 06/17/2025 at 20:30, 1 year 1 month ago GENFIT : Résultats de l’Assemblée Générale Mixte du 17 juin 2025 GENFIT annonce les résultats de son Assemblée Générale Mixte du 17 juin 2025, approuvés avec un quorum de 27,21%, tout en dévoilant sa mission et activités dans le secteur biopharmaceutique Biopharmaceutique Assemblée Générale Mixte Maladies Rares GENFIT Foie
BRIEF published on 05/22/2025 at 22:15, 1 year 2 months ago GENFIT: First Quarter 2025 Financial Results Treasury Royalties GENFIT Iqirvo® Clinical Phase
BRIEF published on 05/22/2025 at 22:15, 1 year 2 months ago GENFIT : Résultats financiers du premier trimestre 2025 Trésorerie Royalties GENFIT Iqirvo® Phase Clinique
PRESS RELEASE published on 05/22/2025 at 22:10, 1 year 2 months ago GENFIT Reports First Quarter 2025 Financial Information GENFIT reports Q1 2025 financial information showing cash position growth and revenue increase. Details on Royalty Financing agreement, research efforts, and corporate governance update included Financial Information Revenue Cash Position GENFIT Q1 2025
Published on 08/07/2026 at 23:15, 9 hours 58 minutes ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 10 hours 13 minutes ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 10 hours 43 minutes ago UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 10 hours 58 minutes ago Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services
Published on 08/07/2026 at 23:21, 9 hours 52 minutes ago EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 13 hours 43 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 13 hours 58 minutes ago ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:10, 15 hours 3 minutes ago Stabilus SE: Andreas Jaeger steps down as Chief Financial Officer at his own request
Published on 08/07/2026 at 18:00, 15 hours 13 minutes ago E-PANGO: Composition du capital au 31 juillet 2026
Published on 08/07/2026 at 18:54, 14 hours 19 minutes ago Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 14 hours 19 minutes ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 14 hours 32 minutes ago Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 14 hours 32 minutes ago Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 15 hours 13 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026
